| Gene symbol | CCNG1 | Synonyms | CCNG | Type of gene | protein-coding | |
| Chromosome | 5 | Map location | 5q34 | dbXrefs | Entrez:900 MIM:601578 HGNC:HGNC:1592 Ensembl:ENSG00000113328 AllianceGenome:HGNC:1592 | |
| Description | cyclin G1 | |||||
| GTO ID | GTC1194 |
| Trial ID | NCT00035919 |
| Disease | Colorectal Carcinoma |
| Altered gene | CCNG1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Mx-dnG1 |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | Tumor Site Specific Phase I Evaluation of Safety of Hepatic Arterial Infusion of a Matrix-Targeted Retroviral Vector Bearing a Dominant Negative Cyclin G1 Construct as Intervention for Colorectal Carcinoma Metastatic to Liver |
| Year | 2002 |
| Country | United States |
| Company sponsor | University of Southern California |
| Other ID(s) | 3C-01-2 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||
|
|||||